C-Reactive Protein Haplotype Predicts Serum C-Reactive Protein Levels But Not Cardiovascular Disease Risk in a Dialysis Cohort
To access this article, please choose from the options below
Support: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study is supported by grant no. RO1-HL-62985 from the National Heart, Lung, and Blood Institute; grant no. RO1-DK-59616 from the National Institute of Diabetes and Digestive and Kidney Diseases; grant no. R01-HS-08365 from the Agency for Healthcare Research and Quality; and a Baxter Healthcare Corporation extramural grant. J.C. is supported in part as an American Heart Association established investigator (01-4019-7N). This project has been funded in whole or part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Potential conflicts of interest: None.
PII: S0272-6386(06)01609-X
doi:10.1053/j.ajkd.2006.10.008
© 2006 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
